Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in...

Area of Science:

• Genetics
• Rheumatology
• Immunology

Background:

• Systemic sclerosis (SSc) is a complex autoimmune disease.
• Microvascular damage is a key feature of SSc pathogenesis.
• The role of specific genetic polymorphisms in SSc susceptibility and clinical manifestations requires further investigation.

Purpose of the Study:

• To explore the association between the Stromal cell-Derived Factor 1 (SDF1)-3' polymorphism and systemic sclerosis (SSc).
• To determine if this polymorphism influences SSc susceptibility or clinical phenotype, including vascular complications.
• To investigate the potential role of SDF1-3' polymorphism in SSc-related pulmonary arterial hypertension (PAH) and skin ulcers.

Main Methods:

• A case-control study involving 150 SSc patients and 150 healthy controls.
• Clinical data collection included skin involvement, autoantibodies, interstitial lung disease, PAH, scleroderma renal crisis, and skin ulcers.
• Genotyping for the SDF1-3' polymorphism was performed using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).

Main Results:

• No significant difference in genotype distribution or allele frequency was observed between SSc patients and controls.
• Frequencies of the SDF1-3'A allele and SDF1-3'GA/AA genotype were significantly higher in SSc patients with PAH and skin ulcers compared to those without.
• The SDF1-3'A allele was identified as a significant risk factor for developing SSc-related PAH and skin ulcers, even after adjusting for age and gender.

Conclusions:

• The SDF1-3'A allele is significantly associated with microvascular involvement in systemic sclerosis.
• This polymorphism may serve as a predictive marker for vascular complications in SSc patients.
• Further research is warranted to elucidate the precise mechanisms underlying this association.